Apart from a study on HDAC1 and HDAC3 expression in breast cancer describing an overexpression of both isoforms (Krusche et al, 2005), reports on expression patterns of distinct HDAC isoforms in tumour entities are sparse and most of the cohorts investigated were of a small sample size. This evidence concerns the gene HDAC3 and breast carcinoma.